These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 209796)

  • 1. Pharmacological profile of BR-931, a new hypolipidemic agent that increases high-density lipoproteins.
    Sirtori CR; Gomarasca P; D'Atri G; Cerutti S; Tronconi G; Scolastico C
    Atherosclerosis; 1978 May; 30(1):45-56. PubMed ID: 209796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of KC-9432, a new hypolipidemic compound, on high density lipoprotein cholesterol in rats.
    Seri K; Sato R; Hamazaki Y; Yamamoto T; Ishiyama N
    Atherosclerosis; 1980 Sep; 37(1):97-102. PubMed ID: 6893550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets.
    Brattsand R
    Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017
    [No Abstract]   [Full Text] [Related]  

  • 4. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
    Ohata I; Sakamoto N; Nitatori R; Maeno H
    Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemia.
    Perova NV; Ozerova IN; Paramonova IV; Olfer'ev AM; Akhmedzhanov NM; Pavlova LI; Oganov RG
    Bull Exp Biol Med; 2001 Apr; 131(4):321-4. PubMed ID: 11550015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
    Bavina MV; Perova NV; Lobova NM; Koropova GI
    Kardiologiia; 1973 Mar; 13(3):27-33. PubMed ID: 4717180
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypolipidemic activity of substances structurally close to penphenone in rats and mice].
    Polikarpova LI; Reznik SE; Ryzhenkov VV; Khechinashvili GG; Petrova LA
    Vopr Med Khim; 1978; 24(6):835-9. PubMed ID: 216145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental hyper-beta-lipoproteinemia and its amelioration by a novel hypolipidemic agent.
    Kobayakawa T; Osuga K; Yasuda H
    Atherosclerosis; 1978 Jul; 30(3):219-25. PubMed ID: 209804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lipid-lowering profile in rodents. AZ-1355, a new dibenzoxazepine derivative.
    Wada S; Koizumi M; Sasahara K; Neichi T; Nakakimura H; Onoda F; Hata SI
    Atherosclerosis; 1981; 40(3-4):263-71. PubMed ID: 7332605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: Formulation, in vitro and in vivo evaluation.
    Omari-Siaw E; Zhu Y; Wang H; Peng W; Firempong CK; Wang YW; Cao X; Deng W; Yu J; Xu X
    Eur J Pharm Sci; 2016 Mar; 85():112-22. PubMed ID: 26851382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouse.
    Reddy JK; Moody DE; Azarnoff DL; Tomarelli RM
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):51-7. PubMed ID: 851495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia.
    Olsson AG; Lang PD
    Atherosclerosis; 1978 Dec; 31(4):421-8. PubMed ID: 215174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aqueous extract of Gleditsia sinensis Lam. fruits improves serum and liver lipid profiles and attenuates atherosclerosis in rabbits fed a high-fat diet.
    Lai P; Du JR; Zhang MX; Kuang X; Li YJ; Chen YS; He Y
    J Ethnopharmacol; 2011 Oct; 137(3):1061-6. PubMed ID: 21718773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma cholesterol and decreased body lipid levels in Wistar rats following pirinixil (BR 931) treatment.
    Kritchevsky D; Klurfeld DM; Tepper SA; Mueller MA; Puglisi L; Sirtori CR
    Pharmacol Res Commun; 1979 Jun; 11(6):475-82. PubMed ID: 504321
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA; Grundy SM
    JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of 5alpha-androstan-3beta, 17beta-diol on serum lipids and lipoproteins and the development of experimental atherosclerosis].
    Sharkevich IN
    Probl Endokrinol (Mosk); 1977; 23(4):99-104. PubMed ID: 198769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats.
    Ohata I; Sakamoto N; Nagano K; Maeno H
    Biochem Pharmacol; 1984 Jul; 33(14):2199-205. PubMed ID: 6466343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. V. On the hypolipidemic and antiatherosclerotic effects of L-ascorbate 2-sulfate in rabbits.
    Hayashi E; Yamada J; Kunitomo M; Terada M; Sato M
    Jpn J Pharmacol; 1978 Feb; 28(1):61-72. PubMed ID: 651017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of gemfibrozil on high-density lipoproteins.
    Glueck C
    Am J Cardiol; 1983 Aug; 52(4):31B-34B. PubMed ID: 6577782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid composition of cholesteryl esters in cholesterol-fed rabbits treated with lipid-lowering agent (ethyl 2-(p-chlorophenoxy) isobutyrate).
    Sato M; Takano T
    Jpn J Pharmacol; 1979 Apr; 29(2):261-9. PubMed ID: 537249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.